CVKD: Cadrenal Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-07 | New 13G stake | The PNC Financial Services Group, Inc. | 8.13% | SEC |
Institutional ownership (Q2 2026)
16 institutions reported holding $278K of Cadrenal Therapeutics, Inc. on Form 13F (17 the quarter before). 5 opened a new position and 6 sold out. Shares held by institutions: +24%.
| Largest holders | Shares | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 50,137 | $167K |
| GEODE CAPITAL MANAGEMENT, LLC | 19,024 | $64K |
| VANGUARD FIDUCIARY TRUST CO | 8,311 | $28K |
| Tower Research Capital LLC (TRC) | 1,282 | $4K |
| UBS Group AG | 1,112 | $4K |
| Grove Bank & Trust | 1,000 | $3K |
| MORGAN STANLEY | 706 | $2K |
| Clearstead Advisors, LLC | 650 | $2K |
| Quest 10 Wealth Builders, Inc. | 380 | $1K |
| OSAIC HOLDINGS, INC. | 300 | $1K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.